Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ADC Therapeutics SA | Chief Financial Officer | Common Shares | 302K | $945K | $3.13 | Dec 6, 2024 | Direct |
Rubius Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 144K | Jan 31, 2022 | Direct | ||
Rubius Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 34.5K | Jan 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADCT | ADC Therapeutics SA | Dec 6, 2024 | 1 | -$151K | 4 | Dec 9, 2024 | Chief Financial Officer |
ADCT | ADC Therapeutics SA | Jan 2, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Chief Financial Officer |
RUBY | Rubius Therapeutics, Inc. | Jan 31, 2022 | 2 | $0 | 4 | Feb 1, 2022 | Chief Financial Officer |